by Zara Qadir – On the occasion of its 40th Anniversary, the European Association of Hospital Pharmacists (EAHP) recorded the highest number of attendees at its annual Congress… read more.
by Zara Qadir – The role of consultant pharmacist was introduced seven years ago by the National Health Service (NHS) in the UK, with the intention of improving… read more.
by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments. There have been many revolutions in medical science over the… read more.
by Zara Qadir – Five years of evolution in Hospital Pharmacy. The 40th EAHP meeting provided an opportunity for Tajda Miharija-Gala and Juraj Sykora, Directors of Professional Development,… read more.
by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.
by Bruce Sylvester taken from the New England Journal of Medicine (NEJM) Vismodegib (Erivedge), a new skin cancer drug for advanced basal cell carcinoma, was called “the greatest… read more.
The antidepressant duloxetine (Cymbalta ®) can effectively treat chemotherapy-induced neuropathy in some patients , researchers reported on July 3, 2012 at the American Society of Clinical Oncology Annual… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – A hormone-depleting drug approved in 2011 for the treatment of metastatic prostate cancer appears to help eliminate… read more.
Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Researchers from a phase 2 study published on March 27 in The Lancet Oncology report that ipilimumab,… read more.
In order to promote the ongoing education in cancer care which is one of the objectives of the association the Cork branch holds an annual education update. In… read more.
Quality-of-life issues gaining prominence as long-term cancer survival rates increase. More than 80 percent of radiation oncologists discuss the impact of cancer treatments on fertility with their patients… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
